TMA 2014

The following videos are experts presenting at TMA – 99th Annual Meeting & Conference held in Williamsburg, Virginia (May 19th-22nd, 2014). The last few years TMA’s Annual Meeting & Conferences have substantially increased foci related to tobacco harm reduction (THR) with emphasis on electronic cigarettes.
conference.tma.org/conference/tmas-99th-annual-meeting-conference

2015 will be the 100th Anniversary of TMA and their Annual Meeting and Conference will be an event not to miss for anyone following THR. www.tma.org/tmalive/FrmMain

Evidence-Based Regulation and Randomized Control Trials (RCTs) Electronic Cigarettes: What We Know Now

Panel Discussion Polosa, Farsalinos, Bullen

Watch Video

Riccardo Polosa, MD, Ph.D.

Riccardo Polosa, MD, Ph.D.

Director, Institute for Internal Medicine & Clinical Immunology at University of Catania, Catania, Italy
Dr. Riccardo Polosa is the Director of the Institute for Internal Medicine and Clinical Immunology of the University of Catania in Italy. He is also in charge of the University’s Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at the University of Southampton, UK. Dr. Polosa has the objective of helping smokers to quit or reduce harm from tobacco cigarettes. He and his team are involved in the evaluation of e-cigarettes and have completed the first RCT in the world on safety and efficacy of e-cigarettes in smokers not willing to quit.
KONSTANTINOS FARSALINOS, MD

KONSTANTINOS FARSALINOS, MD

Researcher at Onassis Cardiac Surgery Center, Athens, Greece
Dr. Konstantinos Farsalinos is a researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging. He has evaluated the effects of smoking on cardiac function, using new echocardiographic imaging techniques. For the past 3 years, he has been actively performing research on electronic cigarettes, at clinical and laboratory level, as well as examining the patterns of electronic cigarette use in experienced consumers. Results of his work were the first ever study on e-cigarette vapor cytotoxicity potential on cultured cells and the first ever study evaluating the clinical effects of electronic cigarette use on cardiac function. He has also performed the biggest international internet survey of e-cigarette users, with more than 19,000 participants. His work has been cited by the European Union when developing the new TPD regulating electronic cigarettes.
CHRISTOPHER BULLEN, Ph.D., MPH

CHRISTOPHER BULLEN, Ph.D., MPH

Director at New Zealand NIHI (via Skype)
Associate Professor Chris Bullen is a medical graduate of the University of Auckland, New Zealand, with postgraduate qualifications in public health (MPH, PhD). He is Director of the National Institute for Health Innovation (NIHI), a multidisciplinary research centre at the University of Auckland, and Co-Director of the Tobacco Control Research Turanga, a $5m Programme of strategic tobacco research aimed at identifying novel ways to reach New Zealand’s Smokefree 2025 goal of a smoking prevalence less than 5%. He has published over 100 papers in peer reviewed journals, many on tobacco control and smoking cessation, including e-cigarettes.

CRO/Laboratory Expert Panel Introduced Q&A Panel Discussion on Funding the Way Forward

Watch Video

  • Dr. Riccardo Polosa, University of Catania, Catania, Italy
  • Dr. Konstantinos Farsalinos, Onassis Cardiac Surgery Center, Athens, Greece
  • Charles Hamshaw-Thomas E-Lites, Inc.
  • John Wiesehan, Jr. Ballantyne Brands-Mistic
  • Christopher Bullen, Ph.D., MPH, New Zealand NIHI (via Skype)
  • Jan Andries Verleur VMR Products
  • David Graham, MPPA NJOY
  • Miguel Martin Logic Technology Development
  • Caroline Cobb, Ph.D., Schroeder Institute for Tobacco Research and Policy Studies at Legacy
  • Joe Gitchell PinneyAssociates
GENE GILLMAN, Ph.D.

GENE GILLMAN, Ph.D.

Laboratory Director at Enthalpy Analytical
Dr. Gillman holds a Ph.D. in organic chemistry from Wake Forest University with an emphasis on chemical toxicology. He has spent his professional career investigating the constituents and chemistry of tobacco smoke. Dr Gillman has extensive experience in developing LC, LC-MS, and GC-MS based test methods. In addition to instrumental methods, he has also developed and published on biological based test methods for the evaluation of cigarette toxicity. He has been involved in the tobacco industry for the past 13 years and has worked for a large cigarette manufacturer and several tobacco industry contract research organizations (CROs). Dr. Gillman is currently the Laboratory Director for Enthalpy Analytical, a CRO specializing in qualitative and quantitative analyses for compounds in tobacco, tobacco smoke, and electronic cigarettes.
DON GRAFF, Ph.D.

DON GRAFF, Ph.D.

Director Tobacco Research at Celerion
Dr. Graff is Director of Tobacco Research at Celerion where he partners with clients to design and implement clinical studies evaluating tobacco products to meet the scientific and regulatory requirements of FDA and other governing bodies.
RANDY COURINGTON

RANDY COURINGTON

Laboratory Director at Arista Laboratories
Randy is a graduate of Virginia Tech with a degree in biochemistry. He spent a dozen years in the pharmaceutical industry developing analytical methods to support clinical drug trials. Randy’s background includes method development for Gas Chromatography, Liquid Chromatography and Mass Spec systems in a variety of biological matrices. Randy joined Arista Laboratories in the spring of 2003 as a scientist and group leader supporting, among other things, the analysis of TSNAs. Randy served as the business development manager from 2007 through 2012 and became the laboratory director in early 2013.

E-Cig Safety, Nicotine Addiction & Smoking Cessation

MICHAEL SIEGEL, MD.

MICHAEL SIEGEL, MD.

Director of Community Health Sciences at Boston University School of Public Health
Watch Video   Dr. Michael Siegel is a Professor in the Department of Community Health Sciences at the Boston University School of Public Health. He has been a researcher in the tobacco control area for the past 24 years. Dr. Siegel has published extensively on a wide range of areas in tobacco, including health effects, secondhand smoke, evaluation of tobacco policy, and national strategies to reduce tobacco use. He has been a leader in the anti-tobacco movement, testifying in support of smoke-free workplace laws and serving as an expert witness in lawsuits against the tobacco companies. He writes a popular tobacco policy blog – The Rest of the Story – where he provides commentary and insight on current tobacco policy issues. His most recent area of research in tobacco control has been the effectiveness and safety of electronic cigarettes for smoking cessation. He recently published two articles on this topic.
SCOTT LEISCHOW, Ph.D.

SCOTT LEISCHOW, Ph.D.

Co-Lead Cancer Prevention & Control Program at The Mayo Clinic
Watch Video   Dr. Scott J. Leischow, joined the Mayo Clinic, in 2012, where he co-leads the Cancer Prevention and Control Program in the Mayo Cancer Center. Dr. Leischow is a behavioral scientist with expertise and interests in tobacco treatment and the role of social networks in the dissemination and implementation of evidence-based practices. His interests include optimal approaches for training health care providers on treating tobacco dependence, as well understanding how complex systems can be understood and optimized to foster improvements in health — particularly in underserved populations in the U.S. and globally.

Panel Discussion – Moderated by Dr. Joel Nitzkin

Watch Video

JOEL NITZKIN, Ph.D. , MD, MPH, DPA

JOEL NITZKIN, Ph.D. , MD, MPH, DPA

American Association of Public Health Physicians
Dr. Nitzkin is a public health physician, board certified in Preventive Medicine as his medical specialty, with a Master’s Degree in Public Health and a Doctorate in Public Administration.
He has served as a local health director (Rochester, New York 1976-1989), State Public Health Director (Louisiana 1989-1992), President of two national public health associations; the National Association of County and City Health Officials (NACCHO), and the American Association of Public Health Physicians (AAPHP). He has served on the Boards of Directors and Executive Committees of several large hospital and health insurance enterprises. He has served on multiple federal advisory committees related to Healthy People, Objectives for the Nation, HIV/AIDS policy, and others. Dr. Nitzkin has been in the private practice of public health as a policy consultant, with his own firm, JLN-MD Associates, LLC, since the mid-1990’s.
Dr, Nitzkin has been involved in tobacco control activities since the late 1970’s. In the mid 1980’s, while Health Director in Rochester, New York, he secured and fully implemented what was, in it’s time, the strictest clean indoor air ordinance in the nation. In the early 1990’s, while State Public Health Director for Louisiana, he secured passage of Louisiana’s first substantial anti-smoking legislation. From early 2007 through mid-2010, Dr. Nitzkin served as Co-Chair of the Tobacco Control Task Force of the American Association of Public Health Physicians (AAPHP). In that capacity, and on behalf of AAPHP, he actively (but unsuccessfully) lobbied Congress for changes to the then-proposed U.S. Food and Drug Administration (FDA) tobacco law to secure amendments to strengthen it from a public health perspective.

Panelists:

  • Dr. Riccardo Polosa, University of Catania, Catania, Italy
  • Dr. Konstantinos Farsalinos, Onassis Cardiac Surgery Center, Athens, Greece
  • Dr. Gil Ross (MD) American Council on Science and Health
  • David Graham, MPPA NJOY
  • Miguel Martin Logic Technology Development
  • Michael Moynihan, Ph.D., MS 22nd Century Group
  • Jonathan Foulds, Ph.D., Penn State College of Medicine

Deeming Impacts on the States and Localities

JEFF STIER, JD

JEFF STIER, JD

Senior Fellow at National Center for Public Policy Research
Watch Video   Jeff Stier is a Senior Fellow at the National Center for Public Policy Research in Washington, D.C., and heads its Risk Analysis Division. Mr. Stier is a frequent guest on CNBC, and has addressed health policy on CNN, Fox News Channel, MSNBC, as well as network newscasts. He does over 100 radio shows a year, including on NPR and other nationally syndicated radio shows, as well as top-rated major market shows in cities including Boston, Philadelphia, and Dallas, plus regional broadcasts.

The ISCD Expert Panelist: Risk Continuum

JONATHAN FOULDS, Ph.D.

JONATHAN FOULDS, Ph.D.

Professor of Public Health Sciences and Psychiatry at Penn State College of Medicine
Watch Video   Jonathan Foulds, Ph.D. is a Professor of Public Health Sciences and Psychiatry at Penn State University, College of Medicine. He trained as a clinical psychologist at the University of Glasgow, and obtained his PhD at the Institute of Psychiatry, University of London. He has spent most of his career developing and evaluating methods to help smokers beat their addiction to tobacco. He was a founding member and Vice President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). He has published over 100 scientific papers and book chapters on tobacco and nicotine and has been invited to speak on smoking cessation in over 17 countries. He acts as a consultant to pharmaceutical companies developing smoking cessation products, and has testified to FDA on behalf of the Society for Research on Nicotine and Tobacco on regulation of nicotine replacement therapies. He is Co-director of the NIH-funded Penn State Tobacco Center of Regulatory Science. He continues to treat addicted smokers, teach on smoking cessation and conduct research on tobacco and health at Penn State College of Medicine in Hershey, PA.

The Path Study

CATHY BACKINGER, Ph.D., MPH

CATHY BACKINGER, Ph.D., MPH

Deputy Director for Research at FDA Center for Tobacco Products
Watch Video   Dr. Cathy Backinger joined the Office of Science, Center for Tobacco Products (CTP), Food and Drug Administration, as Deputy Director for Research in June 2011. She leads a broad-based science and research program addressing the regulatory authorities relevant to the Family Smoking Prevention and Tobacco Control Act including research conducted by CTP, and research conducted in partnership with the National Institutes of Health (NIH), the Centers for Disease Control and Prevention, as well as with FDA’s National Center for Toxicological Research. Dr. Backinger oversees a diverse team of scientists in the areas of tobacco product sciences, non-clinical and environmental sciences, and individual and population health sciences.
Prior to joining CTP in 2011, Dr. Backinger spent over 13 years at the NIH and was Chief of the Tobacco Control Research Branch (TCRB) at the National Cancer Institute, NIH. As Chief, she provided overall leadership for TCRB tobacco-related initiatives and research, as well as dissemination of evidence-based findings to prevent, treat, and control tobacco use. In 2006, she served as program chair for the NIH State-of-the-Science Conference on Tobacco Use: Prevention, Cessation and Control.
Dr. Backinger received a Ph.D. in health policy from the University of Maryland, Baltimore County, an MPH from the University of Michigan and a BS in health education from the Ohio State University.

© 2014 E-Research Foundation. All Rights Reserved.